Oxidized low-density lipoproteins (oxLDL) exhibit proinflammatory properties and play a role in atherosclerosis plaque formation, rupture, and subsequent thrombosis. OxLDL alter the activity of the transcription factor NF-κB that is involved in the expression of immune and inflammatory genes. In contrast, high-density lipoproteins (HDL) are anti-atherogenic and exhibit anti-inflammatory properties. This work aimed to investigate how oxLDL activate NF-κB and whether and how HDL may prevent NF-κB activation. In cultured rabbit smooth muscle cells, mitogenic concentrations of mildly oxLDL trigger a rapid and transient NF-κB activation, which is strongly inhibited by HDL. Growth factors, phosphatidylinositol 3-kinase/Akt, and sphingosine kinase pathways are not implicated in the oxLDL-induced NF-κB activation and are not targets of HDL. OxLDL induce reactive oxygen species (ROS) generation and proteasome activation, which are implicated in NF-κB activation, as suggested by the inhibitory effect of the antioxidants N-acetyl-L-cysteine and pyrrolidinedithiocarbamate and the proteasome inhibitor PSI. HDL were able to prevent the intracellular ROS rise triggered by oxLDL or H 2 O 2 , thereby inhibiting the subsequent proteasome activation, IκB degradation, and NF-κB activation. In conclusion, the oxLDL-induced NF-κB activation involves ROS generation and proteasome activation, both events being inhibited by HDL. This 'antioxidant' and potentially antiinflammatory effect of HDL may participate in their general anti-atherogenic properties.
Triton X-100, [ 32 P]ATP (1 µCi, 20 mM), and MgCl 2 (200 mM). After 30 min of incubation at 37°C, the reaction was stopped by adding 20 µl HCl 1 N and S1P was quantified as described (29) .
Measurement of PI3-kinase activity
PI3-kinase activity was determined on immunoprecipitates of phosphotyrosine proteins prepared from SMC previously incubated with oxLDL (100 µg/ml) ± HDL at the indicated times. PI3-kinase activity was determined according to Burgering et al. (30) .
Determination of proteasome activity
The in vitro activity of the 20S proteasome was determined according to Grüne et al. (31) , under the conditions described in (15) , using the fluorescent substrate sLLVY-MCA.
Western blot analysis
SMC were washed in phosphate-buffered saline (PBS) containing 20 mM sodium fluoride, 20 mM sodium pyrophosphate, 1 mM orthovanadate, and 5 mM EDTA and were allowed to lyse in the described previously conditions (32) . Cell extracts (75 µg as cell protein) were resolved by 12.5% SDS-PAGE, transferred onto nitrocellulose membrane (Hybond-C, Amersham), probed with anti-IκBα or anti-β-actine antibodies, and bound proteins were detected with the ECL detection system (Amersham) using a peroxydase-coupled secondary antibody.
Electrophoretic-molibility shift assay
Cells were washed twice in cold PBS, resuspended in buffer A (10 mM HEPES, 10 mM KCl, 1 mM MgCl 2 , 1 mM dithiothreitol, 0.5 mM EDTA, 0.1mM EGTA, 1 mM PMSF, 2 µg/ml leupeptin, 10 µg/ml aprotinin, and 2 µg/ml pepstatin), and incubated on ice for 15 min. After addition of 1% Igepal, the cells were vigorously mixed and centrifuged (16,000 g, 2 min). Pelleted nuclei were washed once with buffer A, resuspended in 40 µl of buffer B (20 mM HEPES, 400 mM NaCl, 1 mM MgCl 2 , 1mM dithiothreitol, 0.1 mM EGTA, 0.5 mM EDTA, 1 mM PMSF, 2 µg/ml leupeptin, 10 µg/ml aprotinin, and 2 µg/ml pepstatin), incubated 20 min at 4°C under agitation, and centrifuged (16,000 g, 5 min). Nuclear proteins containing supernatants were used for electrophoretic-molibility shift assay experiments.
The double-strand NF-κB oligonucleotide was end-labeled using [γ- 32 P]ATP and T4-polynucleotide kinase and purified on a Qiaquick column (Qiagen, Hilden, Germany). Nuclear extracts (2.5 µg/reaction) were incubated with the radiolabeled probe in 20 µl of buffer [10 mM HEPES, 250 mM NaCl, 5 mM MgCl 2 , 2.5 mM dithiothreitol, 2.5 mM EDTA, 20% glycerol, 1 mg/ml BSA, and 6 µg/ml poly(dI-dC)], and resolved by electrophoresis (33) .
Statistical analysis
Data are given as means ± SE. Estimates of statistical significance were performed by ANOVA (one-way ANOVA, Tukey test, SigmaStat software).
RESULTS
OxLDL (mildly UV-oxidized LDL) trigger the activation of cell signaling pathways involved in SMC proliferation (ROS, sphingolipid signaling, and activation of tyrosine kinase receptors; refs 24, 29, 34) . Most of these cellular responses are due to the presence of bioactive oxidized lipids formed during the oxidation process of LDL. As reported in Table 1 , the three oxidized lipid fractions from LDL (100 µM oxidized cholesterol, oxidized cholesteryl esters, or oxidized phospholipids) elicited (in a dose-dependent manner) intracellular ROS generation, whereas native (nonoxidized) lipids were not active. Under the same experimental conditions, oxidized cholesterol or oxidized phospholipids (but not oxidized cholesteryl esters) triggered activation of the neutral sphingomyelinase (the first enzyme of the Sm/Cer signaling cascade, ref 35) . It may be noted that low concentrations of lipid peroxidation derivative 4-hydroxynonenal (1-10 µM 4-HNE, relevant to its concentration in oxLDL), which trigger EGFR and PDGFR activation (34, 36) , did not trigger ROS generation, whereas higher concentrations (100 µM) did. These data suggest that signaling pathways activated by oxLDL can be mediated by the multiple bioactive oxidized lipids present in oxLDL, in agreement with previous reports (37) .
The present study aimed to clarify the role of these different signaling pathways in the mechanism of NF-κB activation evoked by oxLDL and the protective effect of HDL.
HDL inhibit NF-κB activation and IκB degradation mediated by oxLDL
Gel-shift experiments performed on nuclear extracts from rabbit SMC indicated that mitogenic concentrations of oxLDL (100 µg/ml of UV-oxidized LDL) elicited activation (i.e., nuclear translocation) of NF-κB, in agreement with Cominacini et al. (13; Fig. 1A ). Under the used experimental conditions, NF-κB activation peaked at 30-60 min and decreased progressively in 3 h of incubation with oxLDL (Fig. 1A) . The activation of NF-κB correlated with the degradation of the NF-κB cytosolic inhibitor IκB (Fig. 1B) . Preincubation of SMC with HDL (200 µg/ml) before addition of oxLDL (100 µg/ml) reduced both the oxLDL-induced NF-κB activation (Fig. 1A) and IκB degradation (Fig. 1B) . NF-κB activation was still inhibited in SMC that were preincubated with HDL for 18 h and then washed and finally stimulated by oxLDL (in the absence of HDL; Fig. 1C ). This persistent protective effect does not require any contact between HDL and oxLDL, thus excluding an extraction of bioactive lipids by HDL.
To understand the mechanism of NF-κB activation and that of the protective effect of HDL, we investigated the role of the various mitogenic and survival signaling pathways activated by oxLDL and potentially involved in NF-κB activation.
The Sm/Cer/S1P pathway, including sphingosine kinase, is not the target of HDL and is not involved in oxLDL-induced NF-κB activation
The Sm/Cer/S1P pathway, including sphingosine kinase, is activated by mitogenic concentrations of oxLDL and involved in SMC proliferation (29) . As sphingosine kinase is also implicated in TNF-α-induced NF-κB activation and inhibited by HDL (23), we investigated whether this signaling pathway was involved in oxLDL-induced NF-κB activation and whether it was a target of HDL in our model system.
As previously reported by Auge et al. (29) , oxLDL induced a time-dependent hydrolysis of Sm (peaking at 120-150 min) and a significant activation of cytosolic sphingosine kinase. HDL (200 µg/ml) did not inhibit the Sm hydrolysis nor sphingosine kinase activation induced by oxLDL (Fig. 2, A and B).
We tested then whether the oxLDL-induced NF-κB activation was sensitive to inhibitors of the sphingolipid signaling, such as D-MAPP (a ceramidase inhibitor) and DMS (a sphingosine kinase inhibitor that inhibits sphingosine kinase activation and cell proliferation triggered by oxLDL; Table 2 These data suggest that the sphingolipid signaling pathway (with specific reference to sphingosine kinase) activated by oxLDL and involved in SMC proliferation is not implicated in NF-κB activation in SMC and that inhibition by HDL of the oxLDL-induced NF-κB activation does not occur through an inhibition of this signaling system. The PI3-kinase/Akt pathway and upstream growth factor receptor signaling is not involved in the oxLDL-induced NF-κB activation OxLDL activate the survival PI3-kinase/Akt pathway (38) that is potentially involved in NF-κB activation, because Akt may phosphorylate and activate IKK, which induces IκB phosphorylation and degradation (39) . To investigate this pathway, we used genetically engineered SMC overexpressing ∆p85, a dominant-negative form of p85 in which oxLDL elicit no appreciable activation of PI3-kinase, in contrast to that evoked in control SMC (Fig. 3A) . In contrast to PI3-kinase, NF-κB was activated by oxLDL in ∆p85-SMC, and HDL inhibited this activation (Fig. 3B) . Conversely, the PI3-kinase inhibitors wortmannin and LY294002 did not block (or only poorly) the oxLDL-induced NF-κB activation (data not shown).
These data strongly suggest that, in our model system, the activation of PI3-kinase by oxLDL 1) is not required for NF-κB activation by oxLDL and 2) is not the target of HDL. Therefore, HDL block the oxLDL-induced NF-κB activation independently of the PI3-kinase pathway.
As some of the proliferative effects of oxLDL have been linked to autocrine growth factors mediation (6) and as NF-κB can be activated by growth factors (10, 11), we investigated whether, in our experimental model system, the oxLDL-induced NF-κB activation was mediated by growth factors or other autocrine mediators.
In a first set of experiments, (a lipoprotein-free) preconditioned medium (from SMC pre-treated by oxLDL) was transferred to untreated 'reporter' SMC in order to test its potential mitogenic effect. As shown in Fig. 3C , the preconditioned medium did not activate NF-κB, thus suggesting that autocrine-secreted mediators play apparently no major role in the oxLDL-induced NF-κB activation.
In a second experiment, we investigated whether the main growth factors potentially involved in SMC proliferation triggered NF-κB activation in our model system. Under the experimental conditions used here, FGF-2 and EGF induced a slight NF-κB activation, whereas PDGF was more active (Fig. 3C ). However, in spite of the relatively high concentration used here, the PDGF-induced NF-κB activation remained lower than that obtained with oxLDL. Finally, the PDGF receptor inhibitor AG-1295 slightly inhibited the oxLDL-induced NF-κB activation (Fig.  3D ), thus suggesting that PDGF play only a minor role in our model system. More generally, PDGF receptor signaling plays a moderate role in the mitogenic effect of oxLDL (Table 2) , in agreement with our previous report (40) .
All these data suggest that, in our model system, autocrine mediators or growth factors do not play a major role in the oxLDL-induced NF-κB activation.
OxLDL evoke an early rise of intracellular ROS which is inhibited by HDL
Because NF-κB is a redox-sensitive transcription factor (9, 11) and oxLDL induce a rise of intracellular ROS (13), we hypothesized that HDL may inhibit the oxLDL-induced NF-κB activation through a redox mechanism (i.e., by inhibiting the rise of intracellular ROS).
Incubation of SMC with oxLDL resulted in a rapid increase of intracellular ROS, as assessed by the rise of DCF fluorescence (determined using the fluorogenic ROS-sensitive probe H2DCFDA; Fig. 4A ). HDL (200 µg/ml) completely prevented the ROS increase induced by oxLDL (Fig. 4A) . Similarly, antioxidants (20 mM NAC or 20 µM PDTC) inhibited both intracellular ROS generation and NF-κB activation (Fig. 4 , B and C). These data suggest that ROS are involved in the nuclear translocation and activation of NF-κB triggered by oxLDL and that HDL (like antioxidants) inhibit the rise of intracellular ROS, thereby preventing NF-κB activation.
Because HDL act as an antioxidant and because HDL is a carrier of vitamin E, we investigated the role of vitamin E in this experimental system. This was studied through different experimental approaches. First, addition of 1 or 10 µM vitamin E used in the range of concentrations present in HDL (i.e., 2-3 nmol vitamin E in 200 µg apoA/ml culture medium) did not block the ROS rise nor NF-kappaB activation induced by oxLDL (Fig. 4, B and D) . It may be noted that much higher concentrations of vitamin E (100 µM) were also poorly effective in preventing NF-kappaB activation, in contrast to the hydrophilic antioxidants NAC and PDTC that are highly effective. In the same way, addition of HDL lipid fraction (containing HDLassociated vitamin E) to SMC did not prevent the oxLDL-induced NF-κB activation (Fig. 4E) . Another approach used HDL depleted in vitamin E. Copper-oxidized HDL (oxHDL), containing <0.1 nmol/mg apoA of vitamin E, were still able to reduce the oxLDL-induced NF-kB activation (Fig. 4D) . These data strongly suggest that vitamin E contained in HDL plays no major role in preventing the oxLDL-induced NF-kB activation.
OxLDL trigger proteasome activation that is inhibited by HDL and antioxidants
As the proteasome system is a major (but not unique) pathway required for IκB degradation and subsequent NF-κB activation (9, 41, 42) and as oxLDL (and oxidative stress) are able to stimulate proteasome activity (9, 14, 15) , this led us to evaluate the effect of HDL, the proteasome inhibitor PSI, and antioxidants on the oxLDL-induced activation of proteasome and NF-κB.
OxLDL elicited a first rapid and transient activation of proteasome, which began to rise rapidly and peaked at 15 min, as shown by the hydrolysis of sLLVY-MCA (a fluorogenic synthetic peptide substrate for 20S proteasome; Fig. 5A ). The oxLDL-induced activation of proteasome was completely inhibited by HDL (Fig. 5A ) and by antioxidants PDTC and NAC (Fig. 5B) . In addition, the role of proteasome in oxLDL-induced NF-κB activation was also supported by the inhibitory effect of the proteasome inhibitor PSI (Fig. 5C ).
All these data support the idea that oxLDL-induced proteasome activation is mediated by ROS. HDL act through an inhibition of ROS rise and subsequent proteasome activation triggered by oxLDL.
HDL prevent NF-κB activation triggered by H 2 O 2
To examine whether the antioxidant-like effect of HDL was specific to oxLDL or more general, we tested the effect of HDL on the activation of NF-κB induced by H 2 O 2 .
As shown in Fig. 6 , H 2 O 2 triggered intracellular ROS rise, proteasome activation, and NF-κB activation. HDL were able to reduce the level of H 2 O 2 -induced intracellular ROS (Fig. 6A) , proteasome activation (Fig. 6B) , IκB degradation (Fig. 6C) , and NF-κB activation (Fig. 6D) . These data suggest that HDL exhibit an antioxidant-like activity and counter the sequence of events leading to redox-regulated NF-κB activation (via proteasome and IκB degradation).
DISCUSSION
Intracellular ROS signaling (and oxidative stress) plays a central role in the activation of the transcription factor NF-κB triggered by various inflammatory stimuli, including oxLDL (9, 10). Signaling mechanisms involved in cytokine-induced NF-κB activation are relatively well known (9), but, in contrast, the mechanisms implicated in NF-κB activation triggered by oxLDL and oxidative stress are only partly understood (42, 43) . The data reported here (summarized in Fig.  7 ) suggest that oxLDL (and oxidative stress) trigger the following sequence of events: ROS generation, proteasome activation, IκB degradation, and finally NF-κB activation. The oxLDLinduced activation of signaling pathways such as sphingosine kinase, PI3-kinase, or tyrosine kinase receptors are concomitant lateral events involved in the mitogenic effect but not in NF-κB activation and subsequent proinflammatory response. HDL block the proinflammatory sequence by inhibiting the ROS rise and subsequent events (proteasome activation and NF-κB activation).
These findings clarify the role of signaling pathways in oxLDL-induced NF-κB activation and point out a cellular 'antioxidant' and anti-inflammatory effect of HDL probably of importance in their potent anti-atherogenic effect.
Our data show that nontoxic concentrations of oxLDL trigger ROS generation, which are involved in proteasome activation and subsequent NF-κB activation. OxLDL elicit various cellular redox changes, such as ROS generation (13 and present paper), oxidation of cellular lipids, and glutathione depletion (44) . Cellular ROS generation occurs early (starting to rise at 5 min and peaking at 30-45 min), whereas the oxLDL-induced oxidation of cellular lipids and glutathione depletion are relatively late events (beginning after 6 and 15 h of incubation of cells with oxLDL, respectively; ref 44) . This demonstrates that oxidation of cellular lipids and glutathione depletion do not mediate the early oxLDL-induced NF-κB activation (peaking at 30-60 min). In contrast, the role of the oxLDL-induced rise of intracellular ROS in NF-κB activation is supported by the use of antioxidants NAC and PDTC, in agreement with JanssenHeininger et al. (9) , Cominacini et al. (13) , and Brand et al. (14) . This suggests that ROS implicated in NF-κB activation are probably not generated in the membrane proximity (where vitamin E is located) and are independent of lipid peroxidation (which occurs later and is inhibited by vitamin E; ref 45) . ROS are rather generated and active in the cytosol, where hydrophilic antioxidants are more active than the hydrophobic vitamin E. This also suggests that the 'antioxidant' effect of HDL is not mediated by their content in vitamin E.
The mechanism of NF-κB activation by oxidative stress is only partly understood (11, 42) . NF-κB activation is subsequent to tagging of IκB by phosphorylation and ubiquitination, dissociation of the complex NF-κB/IκB, and degradation of IκB by proteasome (9) . Proteasome is involved in the degradation of oxidized proteins (46, 47) and is implicated in NF-κB activation, either through proteolysis of the p105 and p100 precursors or through degradation of IκB (9, 11, 48) . This led us to investigate the relationship between ROS and proteasome. The reported data show that proteasome activity was redox regulated by the early oxLDL-induced ROS rise and was required for NF-κB activation. These data are in agreement with those reported by Brand et al. (14) in THP-1 monocytic cells.
Another finding is that the mechanism of oxLDL-induced NF-κB activation differs (at least in part) from that mediated by cytokines (TNF-α and IL-1). Indeed, oxLDL activate various signaling pathways involved in cell proliferation, inflammatory response and apoptosis (20, 24, 49) . Among them, the sphingolipid and the PI3-kinase/Akt pathways have been shown to play a role in NF-κB activation triggered by cytokines. Our data show that inhibitors of the sphingosine kinase pathway do not block the oxLDL-induced NF-κB activation, in contrast to their efficacy in blocking NF-κB activation mediated by TNF-α (23). This suggests that the oxLDL-induced NF-κB activation is mediated through signaling pathways different (at least in part) from those activated by TNF. However, an upstream cross talk between the Sm/Cer pathway and ROS generating system cannot be excluded, because ceramide may play a role in the oxLDL-induced ROS formation (34).
PI3-kinase/Akt signaling pathway is apparently not involved in oxLDL-induced NF-κB activation (because PI3-kinase inhibitors and dominant negative ∆p85 do not block the oxLDLinduced NF-κB activation), in agreement with the data of Han et al. (50) . In contrast, PI3-kinase has been shown to be involved in NF-κB activation triggered by pervanadate or cytokines in various cell types (9) but not in endothelial cells (43) . This suggests that (depending on the agonist and the cell type) various alternate signaling pathways may lead to NF-κB activation. Moreover, PI3-kinase is not the target of HDL (present paper). In our model system, it may be concluded that the oxLDL-induced NF-κB activation is (largely) independent of PI3K/Akt signaling pathway and that the inhibitory effect of HDL is not mediated through this system. It may be noted that, in our experimental system, the sphingosine kinase and PI3K/Akt (and upstream tyrosine kinase receptors) are required for the oxLDL-induced SMC proliferation and survival (24, 29) but are not required for NF-κB activation and are not the targets mediating the inhibitory effect of HDL. In contrast, ROS could be involved both in mitogenic/survival signaling, apoptosis, and inflammatory response in vascular cells (51) .
The third finding is the mechanism by which HDL antagonize the sequence of proinflammatory events mediated by oxLDL. HDL are known to counter the atherogenic effect of oxLDL, but so far, the mechanisms of this protective effect at the cellular level, are only poorly understood. Our data show that oxidative signaling plays a major role in NF-κB activation and that HDL are able to prevent this ROS rise, thereby inhibiting the subsequent redox-sensitive signaling (proteasome activation and NF-κB activation) and the subsequent inflammatory response. These data may explain the anti-inflammatory mechanism of HDL, not only against oxLDL-mediated redox signaling but more generally against oxidative stress (as evidenced by their inhibitory effect on H 2 O 2 -induced NF-κB activation; ref 23) . The 'antioxidant' mechanisms by which HDL may prevent the cellular oxidative stress are partly understood. This activity of HDL results (in part) from the associated antioxidant enzymes, namely PAF-acetyl hydrolase (PAF-AH) and paraoxonases (19) . HDL-associated PAF-AH is able to reduce oxidative stress and subsequent macrophage homing to endothelium (52) and paraoxonases may play a role in the antioxidant and cytoprotective effects of HDL (53) . HDL are also able to catalyze the conversion of hydroperoxides into hydroxides (54) . Moreover our data suggest that HDL do not act by extracting the bioactive compounds from oxLDL or by supplying cells with vitamin E. Moreover, as shown by HDL pretreatment (pulse/chase) experiments, the protective effect preventing NF-κB activation was persistent for several hours after HDL removal. It is therefore suggested that HDL could act through a cellular cell signaling leading either to inhibit ROS generation or to reinforce the cellular antioxidant defenses. The precise cellular mechanism is yet unknown but is consistent with the persistent protective effect of HDL against oxLDL-induced toxicity (20) .
From a pathophysiological point of view, atherosclerosis is actually considered as a metabolic and a chronic inflammatory disease (2-6). NF-κB activation is correlated with atherogenesis because activated NF-κB is present in atherosclerotic lesions and is activated in cells treated by oxidative stress and inflammatory stimuli (potentially involved in atherogenesis; refs 7, 8) . NF-κB is involved in the regulation of a variety of genes (e.g., cytokines, chemokines, adhesion molecules, prothrombotic molecules), which play a key role in the inflammatory response of the vascular wall and in initiation or/and progression of atherogenesis (8) . As oxLDL present in atherosclerotic lesions are able to trigger the activation of inflammatory responses in vascular cells and are thought to play a pivotal role in atherogenesis (4-6), it is speculated that the oxLDL-induced NF-κB activation may play a role in the atherogenic process (8) . Conversely, the data reported here suggest that inhibiting the oxLDL-induced ROS generation and NF-κB activation represents a major mechanism by which HDL may counterbalance the proinflammatory signaling triggered by oxLDL, which may explain in part their antiinflammatory and anti-atherogenic properties observed in animal models and of potential interest in clinical use (55).
In conclusion, our data shed light on the pathophysiology of atherosclerosis, by establishing a link between metabolic factors (lipoproteins) and the inflammatory processes acting in atherosclerosis. Two lipoproteins (LDL and HDL) are inversely linked to the inflammatory response: 1) oxLDL are involved (through ROS, proteasome, NF-κB) in inflammatory gene expression and 2) HDL counter this proinflammatory effect of oxLDL by down-regulating the oxLDL-induced cellular signaling (by blocking the rise of intracellular ROS and subsequent events). This may also allows to understand the acute protective (anti-athero-thrombotic effect) of HDL in preventing both atherosclerotic lesion formation and complications. and inhibitory effect of HDL. SMC were incubated with UV-oxLDL (100 µg apoB/ml) with or without HDL (200 µg apoA/ml) (preincubated for 18 h with SMC), and then the nuclear proteins were extracted and EMSA experments were done as indicated in text and quantified by Image Quant. B) Western blot of IκB (and β-actin as a reference). SMC were incubated for 1 h with oxLDL (100 µg/ml) ± HDL (200 µg /ml) (preincubated for18 h). Cell protein extracts were resolved by SDS-PAGE and immunoblotted, and the IκB band was revealed using anti-IκBα polyclonal and β-actin antibodies. C) Persistent effect of HDL. SMC were preincubated for 18 h with HDL (200 µg/ml) and then washed in PBS and stimulated with oxLDL in HDL-free medium for 60 min. Then NF-κB activation was evaluated by EMSA as in , Northern blot experiments on SMC expressing a pRC empty vector (left) or ∆p85, the dominant negative form of the p85 subunit of PtdIns-3K (right), and GAPDH (lower panel), as control. SMC were preincubated (or not) for 18 h with HDL (200 µg/ml), and then oxLDL (100 µg/ml) were added for 2 h. PtdIns-3K activity was determined on phosphotyrosine protein immunoprecipitated with 4G10 antibody, as indicated in experimental procedures section. PtdIns-3K activity is expressed as percentage of unstimulated control and is means ± SE of 5 separate experiments. B) Gel shift experiments performed on ∆p85 SMC preincubated or not with HDL (200 µg/ml) and 1 h stimulated with oxLDL (100 µg/ml). C) Study of the potential role of growth factors or other secreted mediators on the oxLDL-induced NF-κB. Transfer of preconditioned medium was used to investigate whether secreted factors mediate the oxLDL-induced activation of NF-κB. Preconditioned medium was prepared by preincubating SMC for 45 min with oxLDL (100 µg/ml), and then the preincubation medium was discarded and these SMC were incubated for 1 h in oxLDL-free medium. At the end of this 1 h incubation, this preconditioned medium was transferred on untreated reporter SMC, which were incubated for an additional 1 h in the preconditioned medium, and then used to evaluate NF-κB activation. To investigate the effect of growth factors on NF-κB activation, SMC were incubated with 5 ng/ml FGF-2, 10 nM EGF or 10 ng/ml PDGF for 30 min, before harvesting the cells for gel shift assays. D) Gel shift experiments performed on SMC stimulated 1 h with oxLDL (100 µg/ml) in presence or in absence of PDGFR inhibitor tyrosine kinase 10 µM AG 1295 (preincubated with SMC for 15 min before oxLDL addition). In B, C, and D, data representative of 3 separate experiments. 
